All In Biotech

Drug Trial Radar · NCT07099924

Rectus Sheath Catheters Following Midline Laparotomy

Bilateral Rectus Sheath Catheters Following Midline Laparotomy. A Randomized, Placebo-controlled Trial

Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Oct 6, 2025

Primary completion

Aug 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Asklepios Kliniken Hamburg GmbHAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 1, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Rectus sheath catheters (RSC) are used for postoperative analgesia following midline laparotomies. Local anesthetics are applied to the posterior rectus sheath via the RSC. The target structures are the anterior cutaneous branches of the spinal nerves Th7-Th12. RSC can be used in particular if thoracic epidurals are contraindicated (compromised coagulation), technically unfeasible or refused by the patient. The study investigates placebo-controlled weather RSC have a significant additional analgesic effect in a multimodal analgesic concept. Primary outcome parameters are the maximum pain score, the Quality-of-Recovery-15-Score (QoR-15GE) and the opioid consumption (morphine equivalents) in the first 72h postoperatively.

Conditions

  • Acute Abdomen
  • Ileus
  • Colorectal Carcinoma

Interventions

  • Ropivacaine 0.2%Drug

    2x30ml (bilateral) ropivacaine 0.2% every 8 hours via rectus sheath catheter

  • Saline 0.9%Drug

    2x30ml saline 0.9% every 8 hours via rectus sheath catheter

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. patient satisfactionTime frame: on first postoperative day
  2. pain score (numeric rating scale)Time frame: daily up to 72 hours postoperatively
  3. Opioid consumptionTime frame: on the day of surgery, on the first postoperative day, on the second postoperative day, on the third postoperative day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Asklepios Medical Center Uckermark

    Schwedt, Brandenburg, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.